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Introduction
Over time, the prevalence of pre-
diabetes (fasting blood glucose 5.5–6.9
mmol/l) and diabetes has increased
in the United States (US).1–3 People
with diabetes have a higher risk of
heart disease and stroke than people 
without diabetes,4 and those with pre-
diabetes have a higher risk of these 
diseases than those without the pre-
condition.4–7 Thus, intervention pro-
grammes are needed to prevent both
pre-diabetes and diabetes and to con-
trol heart disease risk factors among
people with these conditions.
The Well-Integrated Screening
and Evaluation for Women Across the
Nation (WISEWOMAN)8,9 project is a
US Centers for Disease Control and
Prevention (CDC) funded, multi-
component intervention programme
aimed at reducing heart disease and
stroke risk in low-income, underin-
sured, and uninsured women aged
40–64 years. WISEWOMAN provides
preventive services including blood
pressure (BP), cholesterol, and glu-
cose screening; lifestyle interventions
to help women develop a healthier
diet, increase physical activity, and
quit smoking; referrals for medical
treatment for participants with abnor-
mal values; and one-year follow-up vis-
its to provide feedback to participants
and their providers about changes in
participants’ risk factor profiles.9 The
goal of the programme is to improve
participants’ health by reducing risk,
by offering heart disease and stroke-
prevention activities in conjunction
with the National Breast and Cervical
Cancer Early Detection Program
(NBCCEDP). 
Patient-centered lifestyle pro-
grammes are especially important for
low-income women because they 
typically receive inconsistent care. 
For example, roughly one in five
(18%) working-age women in the US
lacks health insurance,10 and ethnic 
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Abstract
Background: WISEWOMAN provides chronic disease risk factor screening, referrals
and lifestyle interventions to low-income, uninsured women, to reduce their heart
disease and stroke risk. Participants learn behaviour-changing skills tailored to 
low-income populations, such as collaborative goal setting, the need to take small
steps and other empowerment techniques. 
Aim: To quantify the baseline prevalence of pre-diabetes (fasting blood glucose
5.5–6.9 mmol/l) and diabetes among WISEWOMAN participants and assess one-
year changes in glucose levels and other diabetes risk factors. 
Methods: We used 1998–2005 baseline and one-year follow-up data from WISEWOMAN
participants. Using a multilevel regression model, we assessed one-year changes in 
glucose, blood pressure (BP), total cholesterol and 10-year risk of coronary heart 
disease (CHD) among participants with baseline pre-diabetes (n=688) or diabetes (n=338).
Results: At baseline, 15% of participants had pre-diabetes and 10% had diabetes. 
Of those with diabetes, 26% were unaware of their condition before baseline screening.
During the one-year follow-up period, participants with pre-diabetes experienced 
statistically significant improvements in glucose (2.9%) and cholesterol (2.1%) levels
and 10-year CHD risk (4.3%). Participants with newly diagnosed diabetes experienced
statistically significant improvements in glucose (11.5%), BP (3.1%–3.5%) and 
cholesterol (6.4%) levels. Participants with previously diagnosed diabetes experienced
significant improvements in BP (1.9–3.4%), cholesterol level (3.8%), and 10-year CHD
risk (8.5%). 
Conclusions: Implementing patient-centered, comprehensive and multilevel 
interventions and demonstrating their effectiveness will likely lead to the adoption 
of this approach on a much broader scale.
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minority women – even when insured
– are less likely than white women to
have a consistent relationship with 
a healthcare provider.11 Ensuring
access to preventive health serv-ices
requires expanding healthcare cov-
erage, and fostering consistent 
and trusting relationships between
providers and patients.12 Thus, pre-
ventive healthcare strategies that are
sensitive to the economic and cultural
context of women’s lives are needed. 
With funding from Congress in
1995, CDC invited state and territo-
rial departments of health and
tribal agencies to design creative
strategies that would add cardio-
vascular disease (CVD) screening
and lifestyle interventions to breast
and cervical cancer screening 
programmes. Fifteen state and
tribal health agencies now operate
WISEWOMAN projects (Figure 1). 
Using social cognitive theory 
and the socio-ecological model,
WISEWOMAN interventions are tai-
lored to each woman and are
designed to improve participants’ self-
efficacy, self-monitoring, readiness to
change, social support, collaborative
goal-setting and ability to overcome
barriers, by taking small achievable
steps. Many projects also use motiva-
tional interviewing.8,9
Baseline fasting glucose levels
appear to be increasing in WISE-
WOMAN participants (Figure 2),
especially in comparison with the
levels in the general US population
(National Health and Nutrition
Examination Study, 1999–2004).13
Therefore, understanding whether
participation in the WISEWOMAN
programme improves health out-
comes is important for planning
diabetes prevention efforts. The
goal of this paper is to quantify 
the baseline prevalence of pre-dia-
betes and diabetes in WISE-
WOMAN participants, and assess
one-year changes in glucose levels
and other heart disease and stroke
risk factors.
Methods
WISEWOMAN projects
We restricted our analysis to the 10
WISEWOMAN projects that offer
diabetes and pre-diabetes screen-
ings and, at the time of the analysis,
had both baseline and one-year 
follow-up data on participants. 
Data Collection
Programme participants were
screened at baseline and again 10–
14 months later to assess changes in
risk factors. For measurements of BP
and cholesterol, WISEWOMAN proj-
ects follow guidelines from the Joint
National Committee14 and the Adult
Treatment Panel15 for detection,
evaluation and treatment of high BP
and cholesterol levels, respectively.
For example, all projects measured
BP twice during each visit.
At baseline and one-year follow-
up, all projects measured height,
weight, systolic and diastolic BP,
total and high-density lipoprotein
(HDL) cholesterol levels, and blood
glucose levels. Participants were 
also asked whether they had ever
been diagnosed as having diabetes,
high cholesterol, or hypertension
and if so, whether they were 
taking medication to treat these
conditions. Participants also indi-
cated whether they smoked ciga-
rettes. The programmes collected
demographic data on age, race,
Hispanic or Latino origin, and edu-
cation. The WISEWOMAN data col-
lection protocol has been approved
by the RTI International institu-
tional review board.
Definitions
Based on American Diabetes
Association guidelines, participants
were considered to have pre-diabetes
if they had fasting blood glucose 
levels of 5.5–6.9 mmol/l. They 
were considered to have diabetes if
they had fasting blood glucose levels
of ≥7 mmol/l or a self-reported 
history of diabetes, or if they were
taking medication for diabetes.5
Participants who were newly diag-
nosed with diabetes were those with
abnormal glucose values at baseline
(i.e. fasting blood glucose levels ≥7
mmol/l) who reported that they had
never been told by a healthcare pro-
fessional that they had diabetes.
Participants with previously diag-
nosed diabetes were defined as those
who reported having been told by a
healthcare professional that they
had diabetes.4,5
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Figure 1. Location of WISEWOMAN projects funded in 2006
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Measures
We assessed baseline prevalence 
of pre-diabetes and diabetes and
the percentage of newly diagnosed
cases of diabetes among 29 387
WISEWOMAN participants scree-
ned at baseline between January
1998 (North Carolina is the only
project for which screening data
are available from 1998. Other 
projects began screening from 
2000 onwards) and June 2005. 
A total of 23% of programme par-
ticipants screened at baseline were
re-screened one year later. We
assessed one-year changes in CHD
risk factors (systolic and diastolic
BP, total cholesterol, fasting blood
glucose, body mass index [BMI],
smoking prevalence, and 10-year
risk of CHD) in 688 WISEWOMAN
participants with baseline pre-dia-
betes, 83 participants with newly
diagnosed diabetes at baseline, and
260 participants with previously
diagnosed diabetes. 
We calculated the 10-year risk of
developing CHD (including angina
pectoris, recognised and unrecog-
nised myocardial infarction, coronary
insufficiency [unstable angina], and
CHD death) with an algorithm devel-
oped by Anderson et al16 that uses 
age, systolic BP, total and HDL choles-
terol, diabetes and smoking status as
input risk factors. Our rationale for
selecting this algorithm was based on
our previous work demonstrating the
Anderson algorithm to be the most
appropriate calculator for tracking
changes in CHD risk among WISE-
WOMAN participants.17 Age and dia-
betes status remained unchanged
from baseline to follow-up when cal-
culating changes in CHD risk.17
Analysis
We estimated one-year changes in
risk factors using ordinary least
squares regression analysis with the
specified risk factor as the depend-
ent variable and the indicator 
for baseline or follow-up visit as 
the independent variable. We ran
separate regressions for women 
with baseline pre-diabetes, newly
diagnosed diabetes, and previously
diagnosed diabetes. To control for
correlation among participants who
were nested within local project sites,
we ran a multilevel mixed model,
with participant identification (ID)
and state/tribal organisation ID as
grouping variables using the xtmixed
command in Stata.18,19 P-values
≤0.05 were considered significant.
Results
Demographic characteristics of the
WISEWOMAN participants are listed
in Table 1. The percentages of
women with pre-diabetes and dia-
betes, including the numbers of
those newly diagnosed, are given in
Figure 3. The demographic charac-
teristics of the women differed by
diabetes status (Table 1). 
WISEWOMAN participants who
returned for their one-year follow-up
examination showed several statisti-
cally significant improvements in
CVD risk factors (Table 2).
Participants with pre-diabetes experi-
enced statistically significant reduc-
tions in fasting blood glucose level 
(by 0.17 mmol/l or 2.9%, p<0.01),
total cholesterol level (by 0.11 mmol/l
or 2.1%, p<0.01), and 10-year CHD
risk (by 4.3%, p<0.05). Participants
with newly diagnosed diabetes 
experienced statistically significant
reductions in fasting blood glucose
level (by 0.96 mmol/l or 11.5%,
p<0.05), systolic BP (by 4.2 mmHg 
or 3.1%, p<0.05), diastolic BP (by 
2.9 mmHg or 3.5%, p<0.05), and total
cholesterol level (by 0.36 mmol/l 
or 6.4%, p<0.01). Participants with
previously diagnosed diabetes experi-
enced statistically significant reduc-
tions in systolic BP (by 2.5 mmHg 
or 1.9%, p<0.05), diastolic BP (by 
2.7 mmHg or 3.4%, p<0.01), total
cholesterol level (by 0.21 mmol/l
or 3.8%, p<0 .01), smoking rates 
(by 3.8 percentage points or 
23.8%, p<0.01), and 10-year CHD
risk (by 1.1 percentage points or
8.5%, p<0.01). 
Discussion
Our results showed that WISE-
WOMAN participants were at high
risk of diabetes-related complica-
tions at baseline and that their mean
blood glucose values were increasing
over time (Figure 2), emphasising
the need for programmes like WISE-
WOMAN, which reduce fasting
blood glucose values and control
Original Article
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Figure 2. Mean fasting blood glucose values in the US (1999–2004) and in the
WISEWOMAN programme (1998–2005)
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heart disease risk factors among 
people with diabetes or pre-diabetes.
Results of our analysis are subject
to several limitations.  First, we do
not have data on the changes that
would have occurred among this
population in the absence of partici-
pation in WISEWOMAN projects.
An assessment of trends in baseline
risk factors (such as those presented
in Figure 2 for mean blood glucose
values) serves as an imperfect test of
whether secular trends are driving
the results. A decreasing trend in
baseline risk factors across six-
month cohorts of newly enrolled
participants would suggest that
other factors not related to WISE-
WOMAN may be associated with
improvements among participants.
However, over this six-year period,
baseline blood glucose values
among newly enrolled participants
have increased significantly (Figure
2) and baseline BP and cholesterol
values remained unchanged (trend
was not statistically different from
zero, results available upon request).
Even among the general population
of 40–64 year-old women, there is no
evidence of decreasing blood glu-
cose values (Figure 2).  
Secondly, it is unclear whether
the outcomes were a result of a sin-
gle programme component or a
combination. Evidence suggests
that each WISEWOMAN compo-
nent (i.e. screening, lifestyle inter-
vention, referral services, and one-
year follow-up examination) has
been effective in similar popula-
tions.4,14,15,20 Furthermore, in our
previous work we found that some
improvements in CHD risk factors
among women with abnormal risk
factors at baseline can be attributed
to medication use, but most
improvements are probably driven
by a combination of other factors.
These include the receipt of screen-
ing, risk factor counselling and
lifestyle interventions.21
Thirdly, the WISEWOMAN pro-
gramme has a low follow-up rate
(23%). WISEWOMAN participants
are recruited from NBCCEDP; as a
result, women who lose their eligibil-
ity for NBCCEDP because they obtain
health insurance, increase their
incomes, or reach 66 years of age are
automatically ineligible for WISE-
WOMAN. Although we observed
some statistically significant differ-
ences in demographic and baseline
health characteristics between partic-
ipants who returned and those who
did not return for their one-year fol-
low-up examination, the differences
were fairly small (except for smoking
Original Article
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Figure 3. Baseline prevalence of pre-diabetes and diabetes among all 
WISEWOMAN participants screened at baseline (January 1998–June 2005)
Table 1. Demographic characteristics of WISEWOMAN participants with baseline
and follow-up screenings (1998–2005) in 10 projects, by diabetes status (all figures
are percentages)
Variable Pre-diabetes Newly diagnosed Previously
(n=688) Diabetes diagnosed
(n=83) Diabetes
(n=255)
Age (years)
<55 62.8 64.2 51.8 
≥55 37.2 35.8 48.2 
Race or ethnicity
White 54.6 42.0 55.7 
Black 6.4 12.3 14.6 
Hispanic/Latina 12.2 21.0 9.1 
American Indian/ 23.9 18.5 18.6 
Alaska Native
Asian 1.3 2.5 0.4 
Unknown 1.6 3.7 1.6 
Education
< 12 years 18.2 23.4 18.2 
High school graduate 42.2 34.2 45.2 
Some college 38.1 39.7 34.2 
Missing education 1.5 2.7 2.4 
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Table 2: One-year changes in coronary heart disease (CHD) risk factors, by baseline diabetes status
n Baseline Follow-up Percentage p-value
mean (SE) mean (SE) change for % Δ
Pre-diabetes at baseline
SBP, mmHg 639 127.9 127.0 –0.7 0.11
(0.67) (0.65)
DBP, mmHg 637 78.1 77.6 –0.7 0.19
(0.41) (0.41)
TC, mmol/l 688 5.5 5.4 –2.1 0.00
(0.04) (0.04)
Glucose, mmol/l 560 6.0 5.8 –2.9 0.00
(0.01) (0.04)
BMI, kg/m2 601 32.5 32.3 –0.5 0.26
(0.30) (0.31)
Smoking, % 676 22.3 21.6 –3.3 0.41
(1.60) (1.58)
10-year CHD risk, % 602 5.6 5.4 –4.3 0.02
(0.17) (0.17)
Newly diagnosed diabetes
SBP, mmHg 81 134.8 130.6 –3.1 0.03
(2.15) (2.06)
DBP, mmHg 81 81.2 78.3 –3.5 0.02
(1.26) (1.24)
TC, mmol/l 83 5.7 5.4 –6.4 0.00
(0.13) (0.12)
Glucose, mmol/l 59 8.4 7.4 –11.5 0.02
(0.33) (0.35)
BMI, kg/m2 76 34.4 34.3 –0.3 0.85
(1.02) (0.87)
Smoking, % 82 13.4 12.2 –9.1 0.71
(3.79) (3.64)
10-year CHD risk, % 70 12.6 11.6 –8.4 0.07
(0.75) (0.71)
Previously diagnosed diabetes
SBP, mmHg 253 131.7 129.2 –1.9 0.03
(1.14) (1.07)
DBP, mmHg 253 79.0 76.3 –3.4 0.00
(0.63) (0.57)
TC, mmol/l 255 5.5 5.3 –3.8 0.00
(0.07) (0.07)
Glucose, mmol/l 128 7.9 7.7 –2.2 0.50
(0.28) (0.27)
BMI, kg/m2 236 35.1 35.4 0.6 0.20
(0.51) (0.51)
Smoking, % 260 16.1 12.3 –23.8 0.01
(2.29) (2.04)
10-year CHD risk, % 233 12.3 11.2 –8.5 0.00
(0.46) (0.40)
NOTE: SBP = systolic blood pressure, TC = total cholesterol; DBP = diastolic blood pressure; BMI = body-mass index 
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rates, which were 20% among those
who returned and 25% among those
who did not return). 
Finally, diabetes diagnoses were
not confirmed by repeated blood
glucose testing on a different day, 
as recommended by the American
Diabetes Association and World
Health Organization.5,7 Also, WISE-
WOMAN projects are permitted to
use venous and capillary methods to
measure blood glucose levels. 
Our analysis shows that WISE-
WOMAN participants achieved clini-
cally modest improvements in heart
disease and stroke risk factors over a
one-year period. If these small reduc-
tions could be sustained on a popu-
lation-wide level, they could lead to
large reductions in CHD morbidity
and mortality. Moreover, a previous
cost-effectiveness analysis of WISE-
WOMAN has shown that this pro-
gramme compares favourably with
other public health interventions
aimed at improving CHD risk fac-
tors, even when considering the chal-
lenges and barriers of reaching this
financially vulnerable population.22
Potential barriers to reaching 
the low-income, under-insured, and
uninsured women served by WISE-
WOMAN include provider skepti-
cism about women’s ability to
change their behaviours and the
women’s social isolation, unsafe
neighbourhoods and lack of access
to healthy foods:23–26 in some 
locations, for example, neighbour-
hood stores do not stock high-
quality, affordable fruits and vegeta-
bles or low-fat snacks. Because 
the women face many structural 
barriers, WISEWOMAN projects 
are encouraged to use the socio-
ecological model27 to develop multi-
faceted interventions that address
intrapersonal, organisational, com-
munity, and policy influences 
on health and health behaviours.
For example, to strengthen family
and peer support, which has 
been shown to improve health 
outcomes,28–32 some WISEWOMAN
projects now invite relatives and
friends to participate in the inter-
ventions. WISEWOMAN staff work
collaboratively with women to
change their behaviours. 
Organisations are also develop-
ing creative strategies using WISE-
WOMAN funding.33 In North
Carolina, for example, a county
health department clinic partnered
with a community free clinic to
extend its operating hours so that
WISEWOMAN participants could
attend appointments more easily. 
At the community level, some 
projects have hired community
healthcare workers from partici-
pants’ neighbourhoods to conduct
outreach, make telephone calls to
encourage attendance at medical
examinations and intervention ses-
sions, arrange transportation, help
find low-cost medications, and pro-
vide other support services. Some
projects provide discount passes to
encourage exercise in safe environ-
ments or discount coupons to com-
munity weight-loss programmes.
As WISEWOMAN projects
explore ways to serve as agents 
of social change, they are building
alliances among disadvantaged
women and their families, healthcare
providers, and neighbourhoods. The
WISEWOMAN programme’s ability
to eliminate social-group disparities
in diabetes incidence and mortality
probably depends on the strength 
of these alliances. The goal of the
WISEWOMAN programme in pro-
moting more comprehensive inter-
ventions is to empower women to 
use all available services, to facilitate
the adoption of a healthier lifestyle. 
The programme also hopes to 
garner the social support needed 
for behavioural change, raise 
providers’ expectations, build trust
between patients and providers,
ensure that healthcare environments
address the needs of culturally
diverse populations effectively,
remove community barriers to
healthy lifestyles, and create advo-
cates for better healthcare coverage. 
If WISEWOMAN projects can
successfully implement multilevel
interventions and demonstrate
their effectiveness, this approach is
likely to be adopted on a much
broader scale. As progress is made
toward this goal, the WISEWOMAN
programme will begin to realise its
vision of a world where any woman
can access preventive health serv-
ices and gain the wisdom to
improve her health. 
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Appendix A. Selected features the WISEWOMAN programmes.
Feature Connecticut Illinois Massachusetts Missouri Nebraska
Year first funded 2000 2001 1995 2003 2000
Lead agency Connecticut Illinois Department Massachusetts Missouri Department Nebraska
Department of of Public Health Department of of Health and Senior Department of
Public Health Public Health Services Public Health
Participant Women with All recruited Women with All women, All women, 
eligibility for abnormal blood BCCEDP abnormal blood regardless of regardless of 
intervention pressure or participants aged pressure or screening results screening results
cholesterol or who 40–64. cholesterol, and
use tobacco. other CVD risk 
factors.
Features of Hypertension, Hypertension, Hypertension, Hypertension, Hypertension,
baseline abnormal lipid hypercholes- abnormal lipid abnormal lipid abnormal lipid
screenings and values, abnormal terolemia, high values, abnormal values, abnormal values, abnormal
risk factor glucose values, triglycerides, glucose values, glucose values, glucose values, 
assessments abnormal pulse, abnormal glucose overweight, overweight, personal overweight,
overweight, values, abnormal physical inactivity, and family health personal history,
physical inactivity,  pulse, overweight, poor diet, history, poor diet, poor diet,
poor diet, cigarette abdominal obesity, cigarette smoking. physical inactivity, physical 
smoking. personal and family cigarette smoking. inactivity,
medical history, cigarette
cigarette smoking, smoking.
poor diet, physical 
activity.
Features of Adaptation of A A 12-week nutrition Individual Nutritionists, health Cooperative 
Intervention New Leaf …Choices and format activity assessments, educators or Extension
(nutrition and for Healthy Living34 group intervention education, and nursing staff use nutritionists use
physical for nutrition; PACE called Women with lifestyle counseling the A New Leaf... ABCs for Good
activity) program for Heart (based on using the PACE Choices for Healthy Health,37
physical activity.35 Project Active36). program.35 Living34 curriculum. participants
(A Spanish version, Referred to receive
Mujeres con community- based individually
Corazón, is also individual or group tailored nutrition
being used) interventions on and physical 
Sessions with health nutrition and activity
educators focus on physical activity. interventions,
portion sizes, food complete
labels, stress monthly goal
management, and assessment, and
OA Will 41 06 WEB VERSION.qxd  5/6/07  15:19  Page 8
Feature Connecticut Illinois Massachusetts Missouri Nebraska
moderate physical 10,000 Steps
activity program.38,39
Main Outcome Elevated blood Elevated blood Elevated blood Elevated blood Elevated blood 
Variables glucose, glucose, glucose, glucose, glucose,
hypertension and hypertension and hypertension and hypertension and hypertension,
hypercholes- hypercholes- hypercholes- hypercholes- obesity, and
terolemia. terolemia. terolemia. terolemia. hypercholes- 
terolemia.
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Feature North Carolina Southeast Alaska Southcentral  South Dakota Vermont
Regional Health Foundation
Consortium
Year 1995 2000 1999 2000 2000
Lead Agency North Carolina SEARHC Alaska Native South Dakota Vermont 
Department of Community Medical Center Department of Department of
Health and Human Health Services Public Health Public Health
Services Division
Participant BCCEDP All women, All recruited Preference given to All women, 
eligibility for participants aged regardless of BCCEDP women with regardless of 
intervention 40–64 who are screening results. participants aged abnormal screening screening
screened with high 40–64 residing results. Women with results.
serum cholesterol within 50 miles of normal values can
or other abnormal the primary care self-refer to
lipids, elevated center. intervention.
systolic or diastolic 
blood pressure or 
abnormal glucose, 
or a personal history
of these conditions.
Features of Hypertension, Hypertension, Hypertension, Hypertension, Hypertension,
baseline hypercholes- abnormal lipid ypercholes- abnormal lipid abnormal lipid
screenings and terolemia, other values, abnormal terolemia, high values, abnormal values, abnormal
assessments abnormal lipids, glucose values, triglycerides, other glucose values, glucose values,
abnormal glucose overweight, abnormal lipids, overweight, overweight, 
values, overweight, physical inactivity, abnormal glucose personal history, physical 
personal and family poor diet, cigarette values, overweight, physical inactivity, inactivity, poor
medical history, smoking. abdominal obesity, poor diet, cigarette diet, cigarette
cigarette smoking, personal and family smoking. smoking.
poor diet, physical medical history,
inactivity. Research tobacco use,
site includes the poor diet, physical
above plus inactivity.
red blood cell  
membrane fatty 
acid profiles and
blood carotenoids.
Features of A New Leaf... Patient educators A 12-session group There are over 80 Nutritionists use 
intervention Choices for Healthy provide Traditions covering traditional lifestyle motivational 
OA Will 41 06 WEB VERSION.qxd  5/6/07  15:19  Page 9
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Appendix B. Mean fasting glucose values in the United States (1999–2004) and in the WISEWOMAN program (1998–2005)
NHANES
We used data from the 1999–2004 National Health and
Nutrition Examination Survey (NHANES) Laboratory
Assessment: Lab 10AM files from 1999–2000, 2001–2002,
and 2003–2004 to estimate average glucose values among
U.S. women aged 45–65. We estimated 2-year trends in
average fasting glucose values by running a regression on
glucose values with examination years (1999–2000,
2001–2002, or 2003–2004) as an independent variable. To
account for the complex survey design of the NHANES
data, we used svyset and svy: reg commands available in
Stata;17 we weighted the estimates with special fasting
sample weights and estimated standard errors using
appropriate strata and PSU variables. We divided the
estimated 2-year trend (0.0021 mmol, p=0.782) in average
glucose values by four to obtain a 6-month trend (0.005
mmol). We then plotted average fasting glucose values
among U.S. women aged 40-65 for years 1999–2004 using
the estimated 6-month trend (Figure 2).
WISEWOMAN
We used 1998–2005 baseline WISEWOMAN data to
estimate average fasting glucose values among newly
enrolled program participants. We estimated 6-month
trends (0.017, p=0.00) in average fasting glucose levels
by running a regression on glucose values with baseline
screening examination periods as an independent
variable. To account for demographic differences among
WISEWOMAN cohorts enrolled at different time periods,
we controlled for program location and participant age,
race or ethnicity, and level of education. We then plotted
average fasting glucose values among WISEWOMAN
participants for years 1998–2005 using the estimated 6-
month trend (Figure 2).
Feature North Carolina Southeast Alaska Southcentral  South Dakota Vermont
Regional Health Foundation
Consortium
(nutrition and Living.34 In the of the Heart (cultural wellness, nutrition, intervenetionists interviewing to
physical physical community adaptation of physical activity (e.g. nutritionists, provide
activity) center site, women A New Leaf… and tobacco nurses, extension individualized 
also receive follow- Choices for Healthy education topics, educators) across counseling that
up phone calls and Living34 for Native team-taught by the state offering encourage
reminders from Alaskan nutritionists, A New Leaf … women to adopt
community health populations) at exercise Choices for Healthy healthy lifestyles.
workers, and time of screening. physiologists, and Living34 for nutrition They refer to 
referrals to Women also health educators. assessment and their lifestyle 
community referred to group- Includes Traditions counseling; physical intervention as
resources. based nutrition and of the Heart, a activity intervention Turning Over a
physical activity cultural adaptation modeled after New Leaf: 
interventions. for Alaska Natives Project Active.36 Healthy Choices
of A New Leaf... from Ladies 
Choices for Healthy First.
Living.36 Includes 
structured diet and 
physical activity 
assessments,
individual counseling,
and tailored goal-
setting by health 
educators.
Main outcome Elevated blood Elevated blood Elevated blood Elevated blood Elevated blood 
variables glucose, glucose, glucose, glucose, glucose, 
hypertension and hypertension and hypertension and hypertension and hypertension and
hypercholes- hypercholes- hypercholes- hypercholes- hypercholes-
terolemia. terolemia. terolemia. terolemia. terolemia.
BCCEDP: Breast and Cervical Cancer Early Detection Program; PACE: Physician Assisted Counseling and Evaluation; SEARHC:
Southeast Alaska Regional Health Consortium
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Appendix C. Characteristics of women who return and who do not return for a one-year follow-up visit
The low re-screening rate among WISEWOMAN
participants is a concern because women who return
might not be representative of the whole WISEWOMAN
population, biasing the results. For example, women who
return for annual exams might be more likely to take care
of their health and be more motivated to change their
behavior (e.g., improve their diet or increase their physical
activity) than those women who do not return. If so,
women who return have greater improvements in risk
factors than women who do not and our results
overestimate the programmes effectiveness. 
To assess the degree of potential bias introduced by low
re-screening rates, we assessed differences in
demographic and baseline health characteristics between
women who do and do not return for an annual follow-up
visit (Table C-1). Although some of the differences we
found in demographic characteristics were statistically
significant, they were fairly small. However, those who
return are less likely than those who do not return to
smoke at baseline (20% versus 25%) but are more likely
to have baseline hypertension (36% versus 34%). These
results indicate that it is unlikely that our results were
affected by selection bias. 
Characteristic With annual follow-up Without annual p-value of 
exam (n=1026) follow-up exam (n=3307) difference
Age, years 50.5 50.1 0.00
Race or ethnicity (%)
White non-Hispanic 61 61 0.79
Black non-Hispanic 8 9 0.06
Hispanic 14 15 0.02
Asian/Pacific Islander 2 3 0.00
American Indian or Alaska Native 14 10 0.00
Education (%)
Less than 9th grade 10 12 0.00
Some high school 10 11 0.08
High school graduate 44 41 0.00
Some college or higher education 36 36 0.96
Health status (%)
Hypertension (BP ≥140/90 or meds) 36 34 0.03
Abnormal total cholesterol level 
(TC ≥240 or meds) 28 26 0.06
Diabetes (FG ≥126, NFG ≥200, 
self-reported diagnosis, or taking 
medications for diabetes) (%) 9 10 0.07
Obese (BMI ≥30) (%) 33 33 0.89
Smoker (%) 20 25 0.00
BP: blood pressure; TC: total cholesterol; FG: fasting glucose; NFG: nonfasting glucose; BMI: body-mass index. 
Table C-1. Baseline demographic and risk factor characteristics of WISEWOMAN participants with and without 
follow-up exams
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